名稱 | PDGFRA V658A-V561A/BaF3細(xì)胞株 |
型號 | CBP73378 |
報(bào)價(jià) | ![]() |
特點(diǎn) | PDGFRA V658A-V561A/BaF3 |
產(chǎn)品搜索
相關(guān)文章
- 腫瘤免疫藥靶細(xì)胞模型系列——LAG3
- 【連載-企業(yè)參考品】 甲狀腺癌的診斷參考品的選擇
- 【靶點(diǎn)模型+診斷質(zhì)控】FLT3-ITD的藥物開發(fā)和診斷
- 新加坡科學(xué)家找到治療侵襲性卵巢癌的新可能
- 第四代ALK激酶抑制劑篩選模型
- 腫瘤細(xì)胞與正常細(xì)胞的幾大區(qū)別總結(jié)
- atcc細(xì)胞庫的常見冷藏技術(shù)簡介
- 從“腫瘤免疫療法”發(fā)展,看“單抗、CAR-T”任重而道遠(yuǎn)!
- 特定細(xì)胞株的培養(yǎng)條件怎么獲取到呢?
- 【靶點(diǎn)模型+診斷質(zhì)控】c-Kit常見突變的藥物開發(fā)和診斷
聯(lián)系我們
電話:4008750250
號碼:
手機(jī):18066071954
地址:南京市棲霞區(qū)緯地路9號
Email: zhangxiangwen@cobioer.com
產(chǎn)品展示 / PRODUCTS
藥靶細(xì)胞株 > kinase激酶細(xì)胞株 > CBP73378PDGFRA V658A-V561A/BaF3細(xì)胞株

- 詳細(xì)內(nèi)容
CBP73378 | |
I. Introduction | |
Cell Line Name: | PDGFRA V658A-V561A/BaF3 |
Host Cell: | Ba/F3 |
Stability: | 16 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
Freeze Medium: | 90% FBS+10% DMSO |
Complete Culture Medium: | RPMI-1640+10%FBS |
Mycoplasma Status: | Negative |
II.Background | |
PDGFRA, platelet-derived growth factor receptor alpha, is a receptor tyrosine kinase that activates PI3K/Akt, RAS/MAPK, and JAK/STAT pathways to promote cell proliferation and survival (PMID: 21605429). PDGFRA mutations have been detected in melanoma, AML, peripheral nerve sheath tumors, sarcoma, and neuroendocrine carcinomas (PMID: 23752188, PMID: 20685895), several fusions have also been reported (PMID: 22432087, PMID: 26276769), and amplification has been observed in glioblastoma (PMID: 23438035). | |
III. Representative Data | |
1.Sanger of PDGFRA V658A-V561A/BaF3 Figure 1. PDGFRA V658A-V561A/BaF3 V658A Figure 2. PDGFRA V658A-V561A/BaF3 V561A | |
2. Anti-proliferation assay Figure 3. CTG Proliferation Assay of BaF3 PDGFRA V658A Cells (C3). |